Cardiac surgery today is less invasive and more routine and effective than its historic counterpart. Performed percutaneously — via a catheter through the skin — many cardiac procedures no longer require an open heart. Two such procedures performed this way include replacement and repair of the mitral and tricuspid heart valves. Hot on the trail of aortic valve percutaneous intervention, recent percutaneous mitral and tricuspid valve interventions have yielded significant positive outcomes while filling a void in the field of heart surgery. Exploration of this technology in a greater patient population is ongoing, but with promising postoperative results, the innovation has significant implications for the future of cardiac care.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In this video, learn why mitral and tricuspid valve percutaneous procedures are one of Cleveland Clinic’s top 10 medical innovations for 2019.
Advertisement
Advertisement
A sampling of outcome and volume data from our Heart & Vascular Institute
Concomitant AF ablation and LAA occlusion strongly endorsed during elective heart surgery
Large retrospective study supports its addition to BAV repair toolbox at expert centers
Young age, solid tumor, high uptake on PET and KRAS mutation signal risk, suggest need for lobectomy
Surprise findings argue for caution about testosterone use in men at risk for fracture
Residual AR related to severe preoperative AR increases risk of progression, need for reoperation
Findings support emphasis on markers of frailty related to, but not dependent on, age
Provides option for patients previously deemed anatomically unsuitable